Peng Lei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Peng Lei has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Miaomiao Jiang
National Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, China; Haihe Laboratory of Modern Chinese Medicine, Tianjin, China
2 shared publications - Haiyang Yu
Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
1 shared publication - Heshui Yu
College of Pharmaceutical Engineering of Traditional Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin China
1 shared publication Jianbing Dong
1 shared publication- Juanning Ren
State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
1 shared publication - Li-Feng Han
Tianjin Key Laboratory of TCM Chemistry and Analysis, Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 312 Anshan Road, Nankai District, Tianjin 300193, China
1 shared publication
Latest Publications
- Open Access
- 17 July 2025
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 9 (3) , 168
Comprehensive characterization of the material basis and network pharmacology of Dan-Shen-Yin in the treatment of gastritis
Introduction: Dan-Shen-Yin (DSY), a traditional Chinese medicinal prescription composed of Salvia miltiorrhiza Bge. (DS), Santalum album L. (TX) and Amomum villosum Lour. (SR), has been widely employed in the treatment of gastritis in modern clinical practice and demonstrates excellent therapeutic efficacy. However, the main active ingredient and underlying mechanisms of action remain unclear. Objective: The aim of this study is to comprehensively characterize the chemical composition of DSY and elucidate its potential mechanisms in the treatment of gastritis. Methods: The nonvolatile compounds in DSY were analyzed through liquid chromatography-mass spectrometry using the data-dependent acquisition approach, employing an in-house database. The volatile compounds and polysaccharides were detected by gas chromatography-mass spectrometry and high-performance liquid chromatography, respectively. Network pharmacology analysis was performed based on the identified compounds. Results: A total of 52 nonvolatile and 15 volatile compounds were identified in DSY decoction, primarily including phenylpropanoids, phenols, flavonoids, and terpenoids. Specifically, 54 compounds were found in DS, 14 in SR, and 8 in TX. DSY polysaccharide consisted of seven kinds of monosaccharides, including mannose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose, and arabinose, with molar percentages of 0.21%, 0.53%, 0.15%, 4.12%, 6.24%, 18.07%, and 0.84%, respectively. Network pharmacology analysis identified 22 key compounds among the 67 compounds detected. These compounds exert the therapeutic effects through 55 core targets (e.g., interleukin-6, tumor necrosis factor, and TP53) and 10 inflammation-related pathways, such as the MAPK and nuclear factor kappa B signaling pathways. Conclusion: This study further enriches the research on the material basis of DSY and reveals that its volatile compounds, nonvolatile compounds, and polysaccharides contribute to its therapeutic efficacy against gastritis. These findings may facilitate further development and application of DSY in gastritis treatment.
- 17 July 2025
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 9 (3) , 168
Open AccessComprehensive characterization of the material basis and network pharmacology of Dan-Shen-Yin in the treatment of gastritis
Introduction: Dan-Shen-Yin (DSY), a traditional Chinese medicinal prescription composed of Salvia miltiorrhiza Bge. (DS), Santalum album L. (TX) and Amomum villosum Lour. (SR), has been widely employed in the treatment of gastritis in modern clinical practice and demonstrates excellent therapeutic efficacy. However, the main active ingredient and underlying mechanisms of action remain unclear. Objective: The aim of this study is to comprehensively characterize the chemical composition of DSY and elucidate its potential mechanisms in the treatment of gastritis. Methods: The nonvolatile compounds in DSY were analyzed through liquid chromatography-mass spectrometry using the data-dependent acquisition approach, employing an in-house database. The volatile compounds and polysaccharides were detected by gas chromatography-mass spectrometry and high-performance liquid chromatography, respectively. Network pharmacology analysis was performed based on the identified compounds. Results: A total of 52 nonvolatile and 15 volatile compounds were identified in DSY decoction, primarily including phenylpropanoids, phenols, flavonoids, and terpenoids. Specifically, 54 compounds were found in DS, 14 in SR, and 8 in TX. DSY polysaccharide consisted of seven kinds of monosaccharides, including mannose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose, and arabinose, with molar percentages of 0.21%, 0.53%, 0.15%, 4.12%, 6.24%, 18.07%, and 0.84%, respectively. Network pharmacology analysis identified 22 key compounds among the 67 compounds detected. These compounds exert the therapeutic effects through 55 core targets (e.g., interleukin-6, tumor necrosis factor, and TP53) and 10 inflammation-related pathways, such as the MAPK and nuclear factor kappa B signaling pathways. Conclusion: This study further enriches the research on the material basis of DSY and reveals that its volatile compounds, nonvolatile compounds, and polysaccharides contribute to its therapeutic efficacy against gastritis. These findings may facilitate further development and application of DSY in gastritis treatment.
- Open Access
Determination of Trimethylamine N-oxide and Betaine in Serum and Food by Targeted Metabonomics
Trimethylamine N-oxide (TMAO), as a gut-derived metabolite, has been found to be associated with enhanced risk for atherosclerosis and cardiovascular disease. We presented a method for targeted profiling of TMAO and betaine in serum and food samples based on a combination of one-step sample pretreatment and proton nuclear magnetic resonance spectroscopy. The key step included a processing of sample preparation using a selective solid-phase extraction column for retention of basic metabolites. Proton signals at δ 3.29 and δ 3.28 were employed to quantify TMAO and betaine, respectively. The developed method was examined with acceptable linear relationship, precision, stability, repeatability, and accuracy. It was successfully applied to detect serum levels of TMAO and betaine in TMAO-fed mice and high-fructose-fed rats and also used to determine the contents of TMAO and betaine in several kinds of food, such as fish, pork, milk, and egg yolk.
Open AccessDetermination of Trimethylamine N-oxide and Betaine in Serum and Food by Targeted Metabonomics
Trimethylamine N-oxide (TMAO), as a gut-derived metabolite, has been found to be associated with enhanced risk for atherosclerosis and cardiovascular disease. We presented a method for targeted profiling of TMAO and betaine in serum and food samples based on a combination of one-step sample pretreatment and proton nuclear magnetic resonance spectroscopy. The key step included a processing of sample preparation using a selective solid-phase extraction column for retention of basic metabolites. Proton signals at δ 3.29 and δ 3.28 were employed to quantify TMAO and betaine, respectively. The developed method was examined with acceptable linear relationship, precision, stability, repeatability, and accuracy. It was successfully applied to detect serum levels of TMAO and betaine in TMAO-fed mice and high-fructose-fed rats and also used to determine the contents of TMAO and betaine in several kinds of food, such as fish, pork, milk, and egg yolk.